Evolution of the Average Target: Stride, Inc.

Evolution of the Average Target - Stride, Inc.

Evolution of the Target Price: Stride, Inc.

Evolution of the Target Price - Stride, Inc.

Changes in Analyst Recommendations: Stride, Inc.

25a601f9b5fdd94b40d5e4a97e6882._Q9iQY7MhILK4s6OFCJtqK2UIxtDHnfeNXKV4mwsXRM.yWExN72V0OaQsb_KfHU05p3eYSx3SA6sbRv4jShZMHikOA0zo7W2ybCp9g~2b9a4e3222f90e6a0d5b8149906b2a2e
01/08 Stride Shares Fall After William Blair Downgrade MT
31/07 William Blair Downgrades Stride to Market Perform From Outperform MT
29/25/29 Morgan Stanley Lowers Price Target on Stride to $130 From $159, Keeps Equalweight Rating MT
29/25/29 BMO Capital Downgrades Stride to Market Perform From Outperform, Adjusts PT to $108 From $164 MT
06/25/06 Analyst recommendations: Micron, Nike, Stellantis, Microsoft, Newmont Corp… Zonebourse
29/25/29 Barrington Raises Price Target on Stride to $185 From $170, Keeps Outperform Rating MT
06/25/06 Morgan Stanley Raises Price Target on Stride to $159 From $148, Keeps Equalweight Rating MT
06/25/06 Stride Q4 revenue, adjusted EPS beat estimates RE
30/25/30 Barrington Research Adjusts Stride's Price Target to $170 From $150, Keeps Outperform Rating MT
30/25/30 Morgan Stanley Raises Price Target on Stride to $148 From $141, Keeps Equalweight Rating MT
21/25/21 Stride Positioned for 'Beat, Raise' in Fiscal Q3 Amid Strong Enrollments, Morgan Stanley Says MT
21/25/21 Morgan Stanley Raises Price Target on Stride to $141 From $117, Keeps Equalweight Rating MT
29/25/29 Barrington Adjusts Price Target on Stride to $140 From $130, Maintains Outperform Rating MT
23/24/23 Morgan Stanley Raises Price Target on Stride to $94 From $74, Keeps Equalweight Rating MT
21/24/21 Stride Shares Fall After Citigroup Downgrade MT
20/24/20 Citigroup Downgrades Stride to Neutral From Buy, Adjusts Price Target to $90 From $77 MT
08/24/08 Barrington Research Adjusts Stride's PT to $90 From $85, Keeps Outperform Rating MT
08/24/08 Canaccord Genuity Initiates Coverage on Stride With Buy Rating, $94 Price Target MT
31/24/31 Barrington Research Adjusts Stride's Price Target to $85 From $75, Keeps Outperform Rating MT
24/24/24 Morgan Stanley Raises Price Target on Stride to $70 From $65, Cites 'Solid Quarter,' Keeps Equalweight Rating MT
25/24/25 BMO Capital Adjusts Price Target on Stride to $72 From $71, Keeps Outperform Rating MT
25/24/25 Barrington Ups Price Target on Stride to $75 From $70 as Fiscal Q2 Results Surpass Estimates, Maintains Outperform Rating MT
24/24/24 Barrington Research Adjusts Stride's Price Target to $75 From $70, Maintains Outperform Rating MT
16/23/16 BMO Capital Adjusts Stride's Price Target to $67 From $57, Maintains Outperform Rating MT
16/23/16 Morgan Stanley Adjusts Price Target on Stride to $60 From $57, Maintains Equal-Weight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+36.28%
+30.74%
+30.76%
+26.6%
+25.22%
+12.41%
- - +39.51%
+36.7%
+21.93%
- - -22.57%
Average +23.76%
Weighted average by Cap. +26.30%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
78.88USD
Average target price
107.50USD
Spread / Average Target
+36.28%
High Price Target
125.00USD
Spread / Highest target
+58.47%
Low Price Target
90.00USD
Spread / Lowest Target
+14.10%

Analyst Consensus Detail

Analyst consensus - Stride, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Stride, Inc.
Trader
Investor
Global
Quality
ESG MSCI
A
Ratings Surperformance© - Stride, Inc.
  1. Stock Market
  2. Stocks
  3. LRN Stock
  4. Consensus Stride, Inc.